The Quadra Allure MP CRT-P brings MultiPoint™ Pacing (MPP), an exclusive Abbott technology, to cardiac resynchronization therapy Pacemakers (CRT-Ps).

Overview

MPP technology is designed to deliver multiple independent left ventricular (LV) pacing pulses from a single quadripolar lead to provide you with CRT options to change:

• Pattern of depolarization
• Engagement of areas around scar tissue
• Hemodynamics
• Resynchronization

Using the Quadra Allure MP CRT-P with Quartet™ quadripolar LV pacing lead, featuring its four pacing electrodes and 14 pacing vectors, provides more options and greater control in CRT response.
 

U.S. IDE Study: Importance of MPP Technology Programming¹

The recent IDE study¹ post-hoc sub-analysis (n = 199) showed that wider cathode spacing and near-simultaneous intraventricular timing delays provide the best MPP technology response at 87% and “super-response” at 54% (52 Patients).¹

See details of the U.S. IDE study and other clinical support for MPP.
 

Additional International Clinical Data

This evidence builds on our quadripolar standard of care, which has offered you more options to pace at the preferred LV site, resulting in:

• Improved CRT outcome^2,3
• Fewer surgical revisions⁴
• Reduced need for lead repositioning at implant, leading to shorter procedure times and decreased fluoroscopic exposure^5,6
• More basal pacing opportunities without compromising lead stability^7,8

Quadra Allure MP CRT-P Advanced Features and Benefits

Designed to Optimize Tissue Selection

The Quadra Allure MP CRT-P offers Auto VectSelect Quartet™ Test that:

• Automatically identifies tissue sites with the latest activation via RV-LV conduction delay measurements
• Performs threshold testing, assesses LVCap™ Confirm applicability and allows marking of PNS

Pacing at the tissue site of latest activation improves:

• Acute hemodynamic response⁹
• Reverse remodeling¹⁰
• Quality of life¹⁰

Enhanced Programming Options

• SyncAV™ CRT technology automatically adjusts pacing based on real-time changes in a patient’s cardiac condition

Providing Insightful Diagnostics and Radio Frequency (RF) Monitoring

Quadra Allure MP CRT-P helps you better manage your patients’ heart failure with intuitive programming options and timely access to their vital heart failure diagnostic data through RF monitoring, providing:

• CorVue™ congestion monitoring for an earlier insight into HF progression
• Daily remote monitoring of AT/AF alerts for changes in the patient’s AF condition
• DirectTrend™ reports for a simplified look at all device data
  

Building Comprehensive Heart Failure Management

The Quadra Allure MP CRT-P is one of our heart failure management therapies. Our vision is to transform the treatment of heart failure by designing technology that delivers excellent clinical outcomes and improves workflow and efficiency. Read more about our approach to heart failure management.